Results 231 to 240 of about 238,134 (266)

Perioperative Mechanical Circulatory Support for Cardiac Assistance in Thoracic Surgery: A Scoping Review

Artificial Organs, EarlyView.
High‐risk cardiac patients may benefit from timely temporary mechanical circulatory support (tMCS) implantation to provide perioperative hemodynamic stabilization and circulatory support, thus enabling them to undergo life‐saving thoracic surgery. CPB: cardiopulmonary bypass; IABP: intra‐aortic balloon pump; tMCS: temporary mechanical circulatory ...
Viviana Teresa Agosta, Jacopo D’Andria Ursoleo, Alice Bottussi, Samuele Bugo, Fabrizio Monaco   +4 more
wiley   +1 more source

Risk stratification of elderly patients with Brugada syndrome: Results from a large Japanese cohort of idiopathic ventricular fibrillation. [PDF]

J Arrhythm
Shinohara T, Takagi M, Kamakura T, Komatsu Y, Aizawa Y, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M, Aonuma K, Japan Idiopathic Ventricular Fibrillation Study (J‐IVFS) Investigators.   +10 more
europepmc   +1 more source

Impact of Frailty in Patients With Continuous‐Flow Left Ventricular Assist Device Therapy in End‐Stage Heart Failure: A Systematic Review and Meta‐Analysis

Artificial Organs, EarlyView.
Frailty significantly impacts clinical outcomes in LVAD recipients. This systematic review and meta‐analysis reveal that frail patients experience higher long‐term mortality but comparable short‐term mortality, hospital stay, and complication rates to non‐frail patients.
Christos Costa, Arian Arjomandi Rad, Yi Ting Yu, Nithiananthan Mayooran, Andrew Xanthopoulos, Marinos Koulouroudias, Robert Vardanyan, Gustavo Antonio Guida, Lydia Wilkinson, Jan Schmitto, Arjang Ruhparwar, Alina Zubarevich, Alexander Weymann, Peyman Sardari Nia, Antonios Kourliouros, Thanos Athanasiou   +15 more
wiley   +1 more source

Sudden Cardiac Arrest Among Young Competitive Athletes Before and During the COVID-19 Pandemic.

JAMA Netw Open
Astley C, Petek BJ, Delong RN, Kucera KL, Goettsch BP, Harmon KG, Drezner JA.   +6 more
europepmc   +1 more source

Review Article--Exercise and Hypertrophic Cardiomyopathy: Risks, Benefits, and Safety - A Systematic Review and Meta-analysis. [PDF]

J Saudi Heart Assoc
Albulushi A, Abri QA, Tawfek A, Bagheri AR, Al-Hinai S.   +4 more
europepmc   +1 more source

Slow Codes are symptomatic of ethically and legally inappropriate CPR policies

Bioethics, EarlyView.
Abstract Although cardiopulmonary resuscitation (CPR) was initially used very selectively at the discretion of clinicians, the use of CPR rapidly expanded to the point that it was required to be performed on all patients having in‐hospital cardiac arrests, regardless of the underlying condition.
Stuart McLennan, Marieke Bak, Kathrin Knochel   +2 more
wiley   +1 more source

Anomalous origin of the left main coronary artery in a 62‑year‑old woman: a case report and review of the literature. [PDF]

J Cardiothorac Surg
Safariyan M, Mohammadrafie N, Pourmasumi S, Mohammadi V, Xu X, Hermis AH, Al-Jabri MM, Jafarian F, Zakeri MA.   +8 more
europepmc   +1 more source

Potentiating microglial efferocytosis by MFG‐E8 improves survival and neurological outcome after successful cardiopulmonary resuscitation in mice

Brain Pathology, EarlyView.
Schematic representation of the effects of rmMFG‐E8 on post‐CA/CPR brain injury. Ischemic/reperfusion injury caused by CA/RCA results in elevated apoptotic cell death in various cells and decreased apoptotic cell clearance by phagocytes, such as microglia.
Kunxue Zhang, Yuzhen Zhang, Zhentong Li, Jiancong Chen, Yuan Chang, Yongchuan Li, Shuxin Zeng, Sifan Pan, Suyue Pan, Kaibin Huang   +9 more
wiley   +1 more source

Cardiovascular Effects of Antiseizure Medications for Epilepsy. [PDF]

CNS Drugs
Nei M, Ho J, Ho RT.
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source